Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China SXT Pharmaceuticals (SXTC) Prepaid Assets (2018 - 2025)

China SXT Pharmaceuticals has reported Prepaid Assets over the past 8 years, most recently at $319058.0 for Q1 2025.

  • For Q1 2025, Prepaid Assets rose 908.59% year-over-year to $319058.0; the TTM value through Mar 2025 reached $319058.0, up 908.59%, while the annual FY2025 figure was $319058.0, 908.59% up from the prior year.
  • Prepaid Assets for Q1 2025 was $319058.0 at China SXT Pharmaceuticals, up from $31634.0 in the prior quarter.
  • Over five years, Prepaid Assets peaked at $1.9 million in Q1 2021 and troughed at $31634.0 in Q1 2024.
  • A 5-year average of $661029.2 and a median of $319058.0 in 2025 define the central range for Prepaid Assets.
  • Biggest five-year swings in Prepaid Assets: plummeted 86.28% in 2024 and later surged 908.59% in 2025.
  • Year by year, Prepaid Assets stood at $1.9 million in 2021, then tumbled by 53.49% to $864709.0 in 2022, then plummeted by 73.33% to $230642.0 in 2023, then plummeted by 86.28% to $31634.0 in 2024, then surged by 908.59% to $319058.0 in 2025.
  • Business Quant data shows Prepaid Assets for SXTC at $319058.0 in Q1 2025, $31634.0 in Q1 2024, and $230642.0 in Q1 2023.